RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CEVOLI S
Collezione ASL Asti

Items : 4

Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2434-2443. doi: 10.1007/s00415-023-12103-4. Epub 2024 Jan 17.

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D'Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2444-2445. doi: 10.1007/s00415-024-12287-3.

2024
ASL Asti

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Dec;41(Suppl 2):487-488. doi: 10.1007/s10072-020-04669-y.

2020
ASL Asti

Vernieri F; Altamura C; Aurilia C; Brunelli N; Egeo G; Fofi L; Costa CM; Fallacara A; Favoni V; Pierangeli G; Aguggia M; Bertuzzo D; Albanese M; Di Fiore P; Frediani F; Cevoli S; Barbanti P;

Acupuncture vs. Pharmacological Prophylaxis of Migraine: A Systematic Review of Randomized Controlled Trials. in Frontiers in neurology / Front Neurol. 2020 Dec 15;11:576272. doi: 10.3389/fneur.2020.576272. eCollection 2020.

2020
ASL Asti

Giovanardi CM; Cinquini M; Aguggia M; Allais G; Campesato M; Cevoli S; Gentili F; Matrà A; Minozzi S;